2014 Analysis of the Global Animal Health Market Dynamics and Trends

November 2013 | | ID: 22C890F7680EN
Venture Planning Group

Abstracts

This new report from Venture Planning Group analyzes marketing strategies of world's leading animal health companies, including:

• Five-year forecasts for:
• Major market segments
• Key geographic regions
• Assessment of major U. S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics and other technologies.
• Analysis of key market segments
• Review of major geographic areas

Contents

I. INTRODUCTION

II. CHLAMYDIA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
  Chlamydia Psittaci
  Chlamydia Pneumoniae
  Chlamydia Trachomatis
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
E. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton DickinsonTable of Contents (continued)
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Chlamydia Tests
France Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
Germany Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Italy Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Diagnostics Sales by Major Supplier
Spain Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier